These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Efficacy of enfuvirtide in patients infected with drug-resistant HIV-1 in Europe and Australia. Lazzarin A; Clotet B; Cooper D; Reynes J; Arastéh K; Nelson M; Katlama C; Stellbrink HJ; Delfraissy JF; Lange J; Huson L; DeMasi R; Wat C; Delehanty J; Drobnes C; Salgo M; N Engl J Med; 2003 May; 348(22):2186-95. PubMed ID: 12773645 [TBL] [Abstract][Full Text] [Related]
12. Enfuvirtide, an HIV-1 fusion inhibitor, for drug-resistant HIV infection in North and South America. Lalezari JP; Henry K; O'Hearn M; Montaner JS; Piliero PJ; Trottier B; Walmsley S; Cohen C; Kuritzkes DR; Eron JJ; Chung J; DeMasi R; Donatacci L; Drobnes C; Delehanty J; Salgo M; N Engl J Med; 2003 May; 348(22):2175-85. PubMed ID: 12637625 [TBL] [Abstract][Full Text] [Related]
13. A randomized pilot study comparing combination therapy plus enfuvirtide versus a treatment interruption followed by combination therapy plus enfuvirtide. Beatty G; Hunt P; Smith A; Hoh R; Huang W; Martin J; Deeks SG Antivir Ther; 2006; 11(3):315-9. PubMed ID: 16759047 [TBL] [Abstract][Full Text] [Related]
14. T-20 small program, CD4 < 50, will enroll November 27 at 3:00 P.M. James JS AIDS Treat News; 2001 Oct; (373):3. PubMed ID: 11768880 [No Abstract] [Full Text] [Related]
15. Long-term monitoring of genotypic and phenotypic resistance to T20 in treated patients infected with HIV-1. Pérez-Alvarez L; Carmona R; Ocampo A; Asorey A; Miralles C; Pérez de Castro S; Pinilla M; Contreras G; Taboada JA; Nájera R J Med Virol; 2006 Feb; 78(2):141-7. PubMed ID: 16372284 [TBL] [Abstract][Full Text] [Related]
16. Compromised immunologic recovery in treatment-experienced patients with HIV infection receiving both tenofovir disoproxil fumarate and didanosine in the TORO studies. Negredo E; Bonjoch A; Paredes R; Puig J; Clotet B Clin Infect Dis; 2005 Sep; 41(6):901-5. PubMed ID: 16107993 [TBL] [Abstract][Full Text] [Related]